Literature DB >> 17555850

Antibody persistence following booster vaccination against tick-borne encephalitis: 3-year post-booster follow-up.

Pamela Rendi-Wagner1, Maria Paulke-Korinek, Michael Kundi, Ursula Wiedermann, Brigitte Laaber, Herwig Kollaritsch.   

Abstract

In order to evaluate the long-term immunity 2 and 3 years after booster vaccination against tick-borne encephalitis (TBE) following time intervals 3 years and longer since last TBE immunization, 195 (mean age 50.5+/-15.1 years) and 240 subjects (mean age 47.0+/-15.4 years), respectively, who had received a single booster dose in a preceding study, returned for a serological follow-up. Antibody concentrations were measured by neutralization test (NT) and ELISA. Protective TBE antibody levels (NT>or=10) were noted in 96% (187/195) of the subjects at year 2 and 97% (232/240) at year 3 post-booster. At both years, GMTs (NT) of all age groups were above detection limit (>or=2), showing GMT-NT of 54.5 (95% CI: 47.7-62.4) and 69.1 (95% CI: 60.7-78.6), respectively. GMTs were significantly lower in vaccinees>or=50 years of age (p<0.001 for both years). Comparison of GMTs at years 2 and 3 post-booster vaccination with pre-booster values revealed similar antibody titers at all three reading points. Besides an expected rapid decline of TBE antibodies shortly after booster administration, the kinetic curve also suggested maintenance of high values of neutralizing TBE antibodies for a period longer than expected, thus confirming the recent recommendations regarding the extension of TBE booster intervals.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17555850     DOI: 10.1016/j.vaccine.2007.01.116

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  TBE--update on vaccination recommendations for children, adolescents, and adults.

Authors:  Tomas Jelinek
Journal:  Wien Med Wochenschr       Date:  2012-06-12

2.  Insertion of microRNA targets into the flavivirus genome alters its highly neurovirulent phenotype.

Authors:  Brian L Heiss; Olga A Maximova; Alexander G Pletnev
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

3.  Age affects quantity but not quality of antibody responses after vaccination with an inactivated flavivirus vaccine against tick-borne encephalitis.

Authors:  Karin Stiasny; Judith H Aberle; Michael Keller; Beatrix Grubeck-Loebenstein; Franz X Heinz
Journal:  PLoS One       Date:  2012-03-26       Impact factor: 3.240

4.  New endemic foci of tick-borne encephalitis (TBE) identified in districts where testing for TBE was not available before 2009 in Poland.

Authors:  Pawel Stefanoff; Anna Zielicka-Hardy; Maria Hlebowicz; Ryszard Konior; Dariusz Lipowski; Leszek Szenborn; Joanna Siennicka; Hana Orlikova
Journal:  Parasit Vectors       Date:  2013-06-18       Impact factor: 3.876

5.  Factors determining immunological response to vaccination against tick-borne encephalitis virus in older individuals.

Authors:  Pontus Lindblom; Peter Wilhelmsson; Linda Fryland; Andreas Matussek; Mats Haglund; Johanna Sjöwall; Sirkka Vene; Dag Nyman; Pia Forsberg; Per-Eric Lindgren
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.